Cellevate AB
Nils Uhlin has a strong background in sales, marketing, and product management within the pharmaceutical and diagnostic industries. With experience in companies like Cellevate AB and Immunovia AB, Nils has successfully established relations, driven sales growth, and launched new products. Their career also includes positions in IT management and project leadership, showcasing a diverse skill set. Nils Uhlin's strategic approach and accomplishments in establishing key relationships and driving business growth highlight their expertise in the healthcare sector.
Cellevate AB
Cellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3d™ - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3d™ carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing. We offer a range of products based on our versatile and easily functionalized platform for several applications, including next generation cell- and gene therapies. For more information, please visit www.cellevate.com